Skip to main content

Table 2 Severity of adverse reactions after the first and second vaccinations

From: Impact of age, sex and medical history on adverse reactions to the first and second dose of BNT162b2 mRNA COVID-19 vaccine in Japan: a cross-sectional study

Severity

Grade 0

Grade 1

Grade 2

Grade 3

p value

First dose/second dose

First dose/second dose

First dose/second dose

First dose/second dose

n (%)

n (%)

n (%)

n (%)

 

Injection site reaction

102 (22.3)/168 (36.7)

231 (50.4)/190 (41.5)

118 (25.8)/95 (20.7)

7 (1.5)/5 (1.1)

< 0.01

Fatigue

287 (62.7)/201 (43.9)

120 (26.2)/90 (19.7)

46 (10.0)/139(30.3)

5 (1.1)/28 (6.1)

< 0.01

Chills

447 (97.6)/389 (84.9)

9 (2.0)/48 (10.5)

2 (0.4)/21 (4.6)

0/0

< 0.01

Fever

446 (97.4)/346 (75.5)

12 (2.6)/102 (22.3)

0/10 (2.2)

0/0

< 0.01

Arthralgia

339 (87.1)/318 (69.4)

39 (8.5)/67 (14.6)

16 (3.5)/61 (13.3)

4 (0.9)/12 (2.6)

 < 0.01

Myalgia

391 (85.4)/361 (78.8)

39 (8.5)/48 (10.5)

25 (5.5)/41 (9.0)

3 (0.7)/8 (1.7)

0.04

Headache

366 (79.9)/266 (58.1)

52 (11.4)/79 (17.2)

36 (7.9)/90 (19.7)

4 (0.9)/23 (5.0)

< 0.01

Diarrhea

455 (97.2)/439 (95.9)

11 (2.4)/16 (3.5)

0/2 (0.4)

2 (0.4)/1 (0.2)

0.35

Nausea

433 (94.5)/407 (88.9)

18 (3.9)/23 (5.0)

7 (1.5)/27 (5.9)

0/1 (0.2)

< 0.01

Vomiting

453 (98.9)/447 (97.6)

3 (0.7)/9 (2.0)

2 (0.4)/1 (0.2)

0/1 (0.2)

0.22

  1. Values are number of adverse effect after first vaccination/second vaccination. Grade is the severity of each adverse reaction with reference to CTCAE Version 5.0. Chi-square test was performed to examine the difference between the first and second adverse reactions